DDD exit financed with 68 MSEK to develop novel cancer therapy

In June 2022, Marika Nestor’s project aiming to develop a novel cancer therapy left the DDD Platform at SciLifeLab. Six months later, the resulting spin-out company Akiram Therapeutics raised 68 MSEK and is heading for clinical trials in 2024.

DDD exit financed with 68 MSEK to develop novel cancer therapy

Read the full SciLifeLab news item here.